Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU
- Author
- Lieven Annemans (UGent) , Irina Cleemput, Frank Hulstaert and Steven Simoens
- Organization
- Abstract
- Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.
- Keywords
- EU, comparative effectiveness, medical need, level of innovation, orphan medicines, pharmaceutical innovation, personalized medicine
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 442.11 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-5674285
- MLA
- Annemans, Lieven, et al. “Comparative Effectiveness Research and Measuring the Level of Pharmaceutical Innovation in the EU.” JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, vol. 1, no. 1, 2012, pp. 19–29, doi:10.2217/CER.11.1.
- APA
- Annemans, L., Cleemput, I., Hulstaert, F., & Simoens, S. (2012). Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 1(1), 19–29. https://doi.org/10.2217/CER.11.1
- Chicago author-date
- Annemans, Lieven, Irina Cleemput, Frank Hulstaert, and Steven Simoens. 2012. “Comparative Effectiveness Research and Measuring the Level of Pharmaceutical Innovation in the EU.” JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH 1 (1): 19–29. https://doi.org/10.2217/CER.11.1.
- Chicago author-date (all authors)
- Annemans, Lieven, Irina Cleemput, Frank Hulstaert, and Steven Simoens. 2012. “Comparative Effectiveness Research and Measuring the Level of Pharmaceutical Innovation in the EU.” JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH 1 (1): 19–29. doi:10.2217/CER.11.1.
- Vancouver
- 1.Annemans L, Cleemput I, Hulstaert F, Simoens S. Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 2012;1(1):19–29.
- IEEE
- [1]L. Annemans, I. Cleemput, F. Hulstaert, and S. Simoens, “Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU,” JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, vol. 1, no. 1, pp. 19–29, 2012.
@article{5674285,
abstract = {{Over the past 50 years, medicines have made a huge contribution to improving the health status of populations. However, the level of pharmaceutical innovation varies widely, ranging from breakthrough treatments for life-threatening diseases to minor modifications of medicines that have been on the market for some time. Once innovative medicines approach the market, a system of measuring the level of innovation should be established. This perspective describes the current situation, the challenges and initiatives, and formulates recommendations for a coordinated EU action to measure the level of pharmaceutical innovation. In our opinion, comparative effectiveness research needs to play a central role in measuring the level of pharmaceutical innovation.}},
author = {{Annemans, Lieven and Cleemput, Irina and Hulstaert, Frank and Simoens, Steven}},
issn = {{2042-6305}},
journal = {{JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH}},
keywords = {{EU,comparative effectiveness,medical need,level of innovation,orphan medicines,pharmaceutical innovation,personalized medicine}},
language = {{eng}},
number = {{1}},
pages = {{19--29}},
title = {{Comparative effectiveness research and measuring the level of pharmaceutical innovation in the EU}},
url = {{http://doi.org/10.2217/CER.11.1}},
volume = {{1}},
year = {{2012}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: